IFNB1 and central nervous system cancer: In glioma models, IFN-β promoted anti-glioma cytotoxic T cell as well as NK cell activity [45] and glioma cells transfected with IFN-β gene showed enhanced immune recognition via DC and cytotoxic T cells in vitro and in vivo [46].